Items tagged with Treatment
Sequella and Infectex announce results of clinical trial with SQ109 (post)
Sequella and Infectex announced positive results of a Phase 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary TB (MDR-TB). SQ109 is a new small molecule drug discovered by scientists at Sequella and the US National Institutes of Health.
RCDD reports on a new way of screening potential treatments for TB (post)
In a paper published in Scientific Reports scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described a new way of screening potential treatments for Tuberculosis (TB), which may assist in the identification and prioritisation of new therapies which could potentially reduce the duration of current TB treatment.
Development and validation of a prognostic score during TB treatment (post)
A study published in BMC Infectious Diseases derived and validated a prognostic score to predict mortality during TB treatment in high endemicity areas.
India: Drug to treat MDR-TB to be made available across the country (post)
New Delhi, Apr 11 (PTI) The Centre has decided to expand the availability of Bedaquiline, a drug used for treatment of drug-resistant tuberculosis, across the country, the Rajya Sabha was informed today.
Treatment outcomes of TB patients in Ethiopia (post)
Treatment outcomes of tuberculosis patients in nigist Eleni Mohammed general hospital, hosanna, southern nations, nationalities and peoples region, Ethiopia: a five year (June 2009 to August 2014) retrospective study
India to see largest rollout of TB drugs this year (post)
Seven years after the World Health Organisation (WHO) approved guidelines to treat tuberculosis in children, India will become the largest country globally to roll out the world's first easily-dissolvable and flavoured TB drugs.
India to expand access to bedaquiline (post)
The central government has decided to increase access to Johnson & Johnson’s anti-tuberculosis drug as part of its efforts to eradicate the disease by 2025, Reuters reported on Monday. The Health Ministry’s TB division chief Sunil Kharpade said the firm’s breakthrough medicine, Bedaquiline, will be available at 140 government-run tuberculosis treatment centres.
Otsuka aims to apply for delamanid approval in India in 90 days (post)
Japanese drugmaker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis (TB) drug delamanid in India within three months, a senior company official said, as calls grow for expanded access to the life-saving medicine.
Page 30 of 108 · Total posts: 0
←First 29 30 31 Last→